In Vivo Inhibition of Elevated Myocardial β-Adrenergic Receptor Kinase Activity in Hybrid Transgenic Mice Restores Normal β-Adrenergic Signaling and Function

Ovid Technologies (Wolters Kluwer Health) - Tập 100 Số 6 - Trang 648-653 - 1999
Shahab A. Akhter1, Andrea D. Eckhart2, Howard A. Rockman3, Kyle F. Shotwell4, Robert J. Lefkowitz5, Walter J. Koch6
1Shahab A. Akhter From the Departments of Surgery (S.A.A., A.D.E., K.S., W.J.K.) and Medicine and Biochemistry and the Howard Hughes Medical Institute (R.J.L.), Duke University Medical Center, Durham, NC, and the Department of Medicine/Cardiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC (H.A.R.).
2Andrea D. Eckhart From the Departments of Surgery (S.A.A., A.D.E., K.S., W.J.K.) and Medicine and Biochemistry and the Howard Hughes Medical Institute (R.J.L.), Duke University Medical Center, Durham, NC, and the Department of Medicine/Cardiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC (H.A.R.).
3Howard A. Rockman From the Departments of Surgery (S.A.A., A.D.E., K.S., W.J.K.) and Medicine and Biochemistry and the Howard Hughes Medical Institute (R.J.L.), Duke University Medical Center, Durham, NC, and the Department of Medicine/Cardiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC (H.A.R.).
4Kyle Shotwell From the Departments of Surgery (S.A.A., A.D.E., K.S., W.J.K.) and Medicine and Biochemistry and the Howard Hughes Medical Institute (R.J.L.), Duke University Medical Center, Durham, NC, and the Department of Medicine/Cardiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC (H.A.R.).
5Robert J. Lefkowitz From the Departments of Surgery (S.A.A., A.D.E., K.S., W.J.K.) and Medicine and Biochemistry and the Howard Hughes Medical Institute (R.J.L.), Duke University Medical Center, Durham, NC, and the Department of Medicine/Cardiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC (H.A.R.).
6Walter J. Koch From the Departments of Surgery (S.A.A., A.D.E., K.S., W.J.K.) and Medicine and Biochemistry and the Howard Hughes Medical Institute (R.J.L.), Duke University Medical Center, Durham, NC, and the Department of Medicine/Cardiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC (H.A.R.).

Tóm tắt

Background —The clinical syndrome of heart failure (HF) is characterized by an impaired cardiac β-adrenergic receptor (βAR) system, which is critical in the regulation of myocardial function. Expression of the βAR kinase (βARK1), which phosphorylates and uncouples βARs, is elevated in human HF; this likely contributes to the abnormal βAR responsiveness that occurs with β-agonist administration. We previously showed that transgenic mice with increased myocardial βARK1 expression had impaired cardiac function in vivo and that inhibiting endogenous βARK1 activity in the heart led to enhanced myocardial function. Methods and Results —We created hybrid transgenic mice with cardiac-specific concomitant overexpression of both βARK1 and an inhibitor of βARK1 activity to study the feasibility and functional consequences of the inhibition of elevated βARK1 activity similar to that present in human HF. Transgenic mice with myocardial overexpression of βARK1 (3 to 5-fold) have a blunted in vivo contractile response to isoproterenol when compared with non-transgenic control mice. In the hybrid transgenic mice, although myocardial βARK1 levels remained elevated due to transgene expression, in vitro βARK1 activity returned to control levels and the percentage of βARs in the high-affinity state increased to normal wild-type levels. Furthermore, the in vivo left ventricular contractile response to βAR stimulation was restored to normal in the hybrid double-transgenic mice. Conclusions —Novel hybrid transgenic mice can be created with concomitant cardiac-specific overexpression of 2 independent transgenes with opposing actions. Elevated myocardial βARK1 in transgenic mouse hearts (to levels seen in human HF) can be inhibited in vivo by a peptide that can prevent agonist-stimulated desensitization of cardiac βARs. This may represent a novel strategy to improve myocardial function in the setting of compromised heart function.

Từ khóa


Tài liệu tham khảo

Brodde O-E. β-Adrenergic receptors in failing human myocardium. Basic Res Cardiol.. 1993;91:35–40.

10.1016/S0021-9258(20)80439-6

10.1074/jbc.270.30.17953

10.1126/science.7761854

10.1056/NEJM198207223070401

Feldman AM. Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. Circulation.. 1993;87:IV27-IV34.

10.1161/circ.87.2.8381058

10.1161/res.74.2.8293560

10.1161/circ.73.5.3698236

10.1016/S0021-9258(18)53090-8

10.1126/science.1325672

Rockman HA, Choi D-J, Akhter SA, Jaber M, Giros B, Lefkowitz RJ, Caron MG, Koch WJ. Control of myocardial contractile function by the level of β-adrenergic receptor kinase 1 in gene-targeted mice. J Biol Chem.. 1998;293:18180–18184.

10.1172/JCI119381

10.1161/res.79.3.455

10.1074/jbc.272.27.17223

10.1073/pnas.95.12.7000

10.1161/circ.98.17.1783

10.1073/pnas.93.23.12974

10.1016/S0092-8674(00)81878-4

10.1126/science.8160017

Port JD Weinberger HD Bisognano JD Knudson OA Bohlmeyer TJ Pende A Bristow MR. Echocardiographic and histopathologic characterization of young and old transgenic mice over-expressing the human β1-adrenergic receptor. J Am Coll Cardiol. 1998;31(suppl A):177A. Abstract.

10.1073/pnas.94.22.12100

Thông tin
Thông tin xuất bản

Ovid Technologies (Wolters Kluwer Health)

Tập 100 Số 6

648-653

Thông tin tác giả